Citigroup’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.67M Sell
49,388
-106,077
-68% -$5.91M ﹤0.01% 2482
2025
Q4
$8.71M Buy
155,465
+5,231
+3% +$271K 0.01% 1644
2025
Q3
$7.2M Sell
150,234
-100,121
-40% -$4.48M 0.01% 1731
2025
Q2
$10.2M Sell
250,355
-514
-0.2% -$20.7K 0.01% 1357
2025
Q1
$11M Buy
250,869
+250,868
+25,086,800% +$11.1M 0.01% 1308
2024
Q4
$43 Sell
1
-50,000
-100% -$2.27M ﹤0.01% 5722
2024
Q3
$2.22M Buy
50,001
+50,000
+5,000,000% +$2.14M ﹤0.01% 2577
2024
Q2
$40 Hold
1
﹤0.01% 5484
2024
Q1
$43 Sell
1
-400
-100% -$17.2K ﹤0.01% 5526
2023
Q4
$16.7K Hold
401
﹤0.01% 5042
2023
Q3
$15.9K Hold
401
﹤0.01% 4450
2023
Q2
$16.4K Sell
401
-99
-20% -$4.09K ﹤0.01% 4996
2023
Q1
$20.5K Buy
500
+100
+25% +$4.2K ﹤0.01% 4506
2022
Q4
$16.4K Hold
400
﹤0.01% 4666
2022
Q3
$16K Sell
400
-2,496
-86% -$107K ﹤0.01% 4827
2022
Q2
$122K Buy
2,896
+1,340
+86% +$56.2K ﹤0.01% 4118
2022
Q1
$70K Sell
1,556
-98
-6% -$4.31K ﹤0.01% 4590
2021
Q4
$76K Sell
1,654
-466
-22% -$22.1K ﹤0.01% 4875
2021
Q3
$101K Sell
2,120
-4,106
-66% -$204K ﹤0.01% 4416
2021
Q2
$322K Buy
6,226
+291
+5% +$14.6K ﹤0.01% 3967
2021
Q1
$299K Buy
5,935
+274
+5% +$14.6K ﹤0.01% 3785
2020
Q4
$295K Sell
5,661
-512
-8% -$24.5K ﹤0.01% 4677
2020
Q3
$268K Sell
6,173
-1,433
-19% -$62.8K ﹤0.01% 4388
2020
Q2
$327K Sell
7,606
-11,765
-61% -$486K ﹤0.01% 4625
2020
Q1
$699K Sell
19,371
-1,640
-8% -$69.9K ﹤0.01% 3545
2019
Q4
$960K Sell
21,011
-6,842
-25% -$271K ﹤0.01% 3795
2019
Q3
$991K Buy
27,853
+5,176
+23% +$192K ﹤0.01% 3663
2019
Q2
$903K Buy
22,677
+9,904
+78% +$390K ﹤0.01% 3751
2019
Q1
$531K Sell
12,773
-1,159
-8% -$47.1K ﹤0.01% 4120
2018
Q4
$510K Sell
13,932
-47,280
-77% -$2.02M ﹤0.01% 4110
2018
Q3
$2.97M Buy
61,212
+148
+0.2% +$7.01K 0.01% 2351
2018
Q2
$2.63M Buy
61,064
+399
+0.7% +$16.8K ﹤0.01% 2448
2018
Q1
$2.54M Sell
60,665
-805
-1% -$35.1K ﹤0.01% 2388
2017
Q4
$2.67M Sell
61,470
-1,401
-2% -$59.6K 0.01% 2398
2017
Q3
$2.67M Buy
62,871
+503
+0.8% +$21.3K ﹤0.01% 2358
2017
Q2
$2.68M Sell
62,368
-64,543
-51% -$2.72M 0.01% 2279
2017
Q1
$5.31M Buy
126,911
+55,795
+78% +$2.27M 0.01% 1622
2016
Q4
$2.78M Buy
71,116
+64,416
+961% +$2.62M 0.01% 2549
2016
Q3
$296K Buy
6,700
+200
+3% +$9.08K ﹤0.01% 4362
2016
Q2
$272K Sell
6,500
-50,227
-89% -$2.13M ﹤0.01% 4222
2016
Q1
$2.28M Buy
56,727
+487
+0.9% +$20.6K 0.01% 2341
2015
Q4
$2.88M Sell
56,240
-102,200
-65% -$5.21M 0.01% 2198
2015
Q3
$7.43M Buy
158,440
+151,970
+2,349% +$9.15M 0.02% 1363
2015
Q2
$403K Sell
6,470
-1,636
-20% -$102K ﹤0.01% 3904
2015
Q1
$501K Buy
8,106
+1,996
+33% +$118K ﹤0.01% 3744
2014
Q4
$330K Sell
6,110
-670
-10% -$36.6K ﹤0.01% 4260
2014
Q3
$359K Hold
6,780
﹤0.01% 3785
2014
Q2
$352K Sell
6,780
-100,056
-94% -$4.83M ﹤0.01% 3694
2014
Q1
$5M Hold
106,836
0.01% 1692
2013
Q4
$4.7M Buy
106,836
+99,510
+1,358% +$4.14M 0.01% 1876
2013
Q3
$282K Hold
7,326
﹤0.01% 3880
2013
Q2
$258K Buy
+7,326
New +$247K ﹤0.01% 4065

Other funds holding XPH